A Randomized, Controlled Phase II Trial of Neoadjuvant Ado-Trastuzumab Emtansine, Lapatinib, and Nab-Paclitaxel Versus Trastuzumab, Pertuzumab, and Paclitaxel in HER2-positive Breast Cancer (TEAL Study)
Breast Cancer Research - United Kingdom
doi 10.1186/s13058-019-1186-0
Full Text
Open PDFAbstract
Available in full text
Date
September 2, 2019
Authors
Publisher
Springer Science and Business Media LLC